BIOSENSE WEBSTER INC OCTARAY MAPPING CATHETER; CATHETER, INTRACARDIAC MAPPING, HIGH-DENSITY ARRAY
|
Back to Search Results |
|
Catalog Number D160903 |
Device Problems
Contamination /Decontamination Problem (2895); Manufacturing, Packaging or Shipping Problem (2975)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 12/13/2023 |
Event Type
malfunction
|
Event Description
|
It was reported that a patient underwent an atrial fibrillation (afib) ablation procedure with a octaray mapping catheter and it looked like it may be some sort of ¿resin¿ like material on the device.It was also reported by the bwi representative that upon opening the package for the octaray mapping catheter they noticed some "fabric or some type of resin" embedded on the device; on the electrodes.Upon replacing the catheter the issue was resolved and the procedure continued.There was no patient consequence.Additional information was later received indicating the device was used on the patient and the issue was not noticed prior to use on patient.As such, follow up for clarification is in progress.
|
|
Manufacturer Narrative
|
This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by biosense webster inc., or its employees that the report constitutes an admission that the product, biosense webster inc., or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's ref.(b)(4).
|
|
Manufacturer Narrative
|
It was reported that a patient underwent an atrial fibrillation (afib) ablation procedure with a octaray mapping catheter and it looked like it may be some sort of ¿resin¿ like material on the device.It was also reported by the bwi representative that upon opening the package for the octaray mapping catheter they noticed some "fabric or some type of resin" embedded on the device; on the electrodes.Upon replacing the catheter the issue was resolved and the procedure continued.There was no patient consequence.Device evaluation details: the product was returned to biosense webster inc (bwi) for evaluation and the evaluation has been completed.A visual inspection evaluation of the returned device was performed following bwi procedures.Visual analysis of the returned sample revealed a plastic foreign material attached to the splines.For this reason, a fourier transform infrared spectroscopy (ft-ir) was requested, and the analysis revealed that the foreign material showed the absorption bands for polytetrafluoroethylene (ptfe) based material.Since ptfe material was found, an eeprom integrity test verification was performed and it was confirmed that the device was used.Additionally, a picture was received for evaluation.According to pictures provided by the customer, a large foreign material was observed next with the octaray.A manufacturing record evaluation was performed for the finished device batch number, and no internal actions were identified.The issue reported by the customer was confirmed.The ptfe particle could be related to the interaction with the sheath; however, this cannot be conclusively determined.The instructions for use contain the following recommendations: do not introduce the catheter into a guiding sheath with the catheter¿s distal spines folded back toward the handle.Collapse the spines together using the insertion tube prior to insertion as part of biosense webster¿s quality process, all devices are manufactured, inspected, and released to approved specifications.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's ref.# (b)(4).
|
|
Manufacturer Narrative
|
On 22-feb-2024, the bwi product analysis lab received the complaint device for evaluation.The product analysis has begun but is not completed at this time.When the investigational analysis has been completed, a supplemental 3500a report will be submitted.Additionally, the manufactured date and expiration date have been provided.Therefore, fields d4.Expiration date and h4.Device manufacture date have been populated.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's ref.# (b)(4).
|
|
Search Alerts/Recalls
|
|
|